Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
US5462924A · kind A · utility
2Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 1993 |
| Grant date | Oct 31, 1995 |
| Priority date | — |
| Expiry date | Feb 23, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/198
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
IGF-1 is administered to a patient for the treatment or prevention of atrophy of the gut mucosa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.